Why These Five Stocks Are Trending Today?
The US stock market plunged after the bell on the back of April nonfarm payrolls data, which showed that 160,000 jobs were created last month, versus 200,000 expected.
Sanofi Aventis (SNY)
Market is closed
News
- First
- << Previous
- 141 - 150
- Next >>
Why These Five Stocks Are on the Move Today?
Markets are trading lower on Friday following the recent sell-off in several tech stocks amid the earnings season.
Why Investors Are Buzzing About These Stocks Today
It's M&A Thursday, as several major M&A deals have been announced today.
Warren Buffett’s Best High-Yield Dividend Stocks
At the end of 2015, Warren Buffett owned a total of 44 publicly-traded stocks.
Here is What Hedge Funds Think About Sanofi SA (ADR) (SNY)
The elite funds run by legendary investors such as Dan Loeb and David Tepper make hundreds of millions of dollars for themselves and their investors by spending enormous resources doing research on small...
Billionaire Ken Fisher's Top Healthcare Stock Picks
At the beginning of September, when the U.S stock markets were in turmoil, Ken Fisher of Fisher Asset Management asserted that the August correction would be “over just as fast as it began”, and he...
This is What Hedge Funds Have to Say about Two Healthcare Stocks on the Move
Novo Nordisk A/S (ADR) (NYSE:NVO) and Sanofi SA (ADR) (NYSE:SNY) are two healthcare companies that recently received product approval in the US and Europe, respectively, but both stocks did not move significantly...
11 Biggest Generic Drug Companies in the World
When it comes to 11 Biggest Generic Drug Companies in the World one can say that the list hasn’t changed a great deal over the years.
For Sanofi SA (ADR) (SNY) Chronic Diseases Present the Future Focus
In an interview with CNBC, Chris Viehbacher, the CEO of Sanofi SA (ADR) (NYSE:SNY), discussed the steps that big pharma companies like Sanofi SA (ADR) (NYSE:SNY) are taking to tackle chronic diseases ...
Sanofi-Aventis Purchases $42.4 Million Worth of Regeneron Pharmaceuticals Inc (REGN)’s Stock
On Jan. 29th, Sanofi-Aventis, a European pharmaceutical group and Large Shareholder at Regeneron Pharmaceuticals Inc (NASDAQ:REGN), filed a Form 4 report at the U.S.
- First
- << Previous
- 141 - 150
- Next >>
Billionaire Hedge Funds
